{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:18:15Z","timestamp":1793121495977,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-026-02086-5","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T01:46:43Z","timestamp":1771292803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative value of postoperative inflammatory indices in predicting recurrence in T3 stage renal cell carcinoma: superiority of the Cally index"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5200-698X","authenticated-orcid":false,"given":"Mustafa","family":"Sesli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3745-1880","authenticated-orcid":false,"given":"Ahmet Alper","family":"Ozdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9873-4920","authenticated-orcid":false,"given":"Mert","family":"Basaranoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2097-9853","authenticated-orcid":false,"given":"Ahmet","family":"Karakeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7827-4840","authenticated-orcid":false,"given":"\u0130rfan","family":"Orhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7669-414X","authenticated-orcid":false,"given":"Erdem","family":"Akbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"1","key":"2086_CR1","first-page":"7","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A, Cancer statistics. 2017. CA Cancer J Clin. 2017;67(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"6 Pt 1","key":"2086_CR2","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/j.juro.2006.07.130","volume":"176","author":"L Lipworth","year":"2006","unstructured":"Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol. 2006;176(6 Pt 1):2353\u20138.","journal-title":"J Urol"},{"issue":"16","key":"2086_CR3","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.3390\/cancers14164059","volume":"14","author":"T Makino","year":"2022","unstructured":"Makino T, Kadomoto S, Izumi K, Mizokami A. Epidemiology and prevention of renal cell carcinoma. Cancers (Basel). 2022;14(16):4059.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"2086_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4274\/uob.82","volume":"13","author":"O Bozkurt","year":"2014","unstructured":"Bozkurt O, Demir \u00d6. Adjuvant and neoadjuvant targeted therapies in locally advanced renal cell carcinoma. Bull Urooncol. 2014;13(3):139\u201345.","journal-title":"Bull Urooncol"},{"issue":"6","key":"2086_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1586\/14737140.7.6.847","volume":"7","author":"A Breda","year":"2007","unstructured":"Breda A, Konijeti R, Lam JS. Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection. Expert Rev Anticancer Ther. 2007;7(6):847\u201362.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"2086_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11934-017-0661-3","volume":"18","author":"JM Speed","year":"2017","unstructured":"Speed JM, Trinh Q-D, Choueiri TK, Sun M. Recurrence in localized renal cell carcinoma: a systematic review of contemporary data. Curr Urol Rep. 2017;18(2):15.","journal-title":"Curr Urol Rep"},{"issue":"3","key":"2086_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/aam.aam_56_18","volume":"18","author":"N Singh","year":"2019","unstructured":"Singh N, Baby D, Rajguru J, Patil P, Thakkannavar S, Pujari V. Inflammation and cancer. Ann Afr Med. 2019;18(3):121\u201326.","journal-title":"Ann Afr Med"},{"issue":"11","key":"2086_CR8","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1177\/00031348241248693","volume":"90","author":"K Nakashima","year":"2024","unstructured":"Nakashima K, Haruki K, Kamada T, Takahashi J, Tsunematsu M, Ohdaira H, et al. Usefulness of the C-Reactive protein (CRP)-Albumin-Lymphocyte (CALLY) index as a prognostic indicator for patients with gastric cancer. Am Surg. 2024;90(11):2703\u20139.","journal-title":"Am Surg"},{"issue":"8","key":"2086_CR9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10654-021-00752-6","volume":"36","author":"TH N\u00f8st","year":"2021","unstructured":"N\u00f8st TH, Alcala K, Urbarova I, Byrne KS, Guida F, Sandanger TM, et al. Systemic inflammation markers and cancer incidence in the UK biobank. Eur J Epidemiol. 2021;36(8):841\u20138.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"2086_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.clgc.2021.10.009","volume":"20","author":"MD Cordeiro","year":"2022","unstructured":"Cordeiro MD, Ilario EN, Abe DK, de Carvalho PA, Muniz DQB, Sarkis AS, et al. Neutrophil-to-Lymphocyte ratio predicts cancer outcome in locally advanced clear renal cell carcinoma. Clin Genitourin Cancer. 2022;20(2):102\u20136.","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"2086_CR11","doi-asserted-by":"publisher","first-page":"748","DOI":"10.21873\/cdp.10391","volume":"4","author":"S Hirata","year":"2024","unstructured":"Hirata S, Fujii N, Oka S, Nakamura K, Shimizu K, Kobayashi K, et al. C-reactive Protein-albumin-lymphocyte index as a novel biomarker for progression in patients undergoing surgery for renal cancer. Cancer Diagnosis Prognosis. 2024;4(6):748\u201353.","journal-title":"Cancer Diagnosis Prognosis"},{"issue":"1","key":"2086_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12894-020-00665-8","volume":"20","author":"Y Shao","year":"2020","unstructured":"Shao Y, Wu B, Jia W, Zhang Z, Chen Q, Wang D. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis. BMC Urol. 2020;20(1):90.","journal-title":"BMC Urol"},{"issue":"3","key":"2086_CR13","doi-asserted-by":"publisher","first-page":"e685","DOI":"10.1016\/j.clgc.2018.01.010","volume":"16","author":"A Semeniuk-Wojta\u015b","year":"2018","unstructured":"Semeniuk-Wojta\u015b A, Lubas A, Stec R, Syry\u0142o T, Niemczyk S, Szczylik C. Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, and C-reactive protein as new and simple prognostic factors in patients with metastatic renal cell cancer treated with tyrosine kinase inhibitors: A systemic review and Meta-analysis. Clin Genitourin Cancer. 2018;16(3):e685\u201393.","journal-title":"Clin Genitourin Cancer"},{"issue":"12","key":"2086_CR14","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s00345-015-1559-7","volume":"33","author":"I Lucca","year":"2015","unstructured":"Lucca I, de Martino M, Hofbauer SL, Zamani N, Shariat SF, Klatte T. Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma. World J Urol. 2015;33(12):2045\u201352.","journal-title":"World J Urol"},{"issue":"6","key":"2086_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.urolonc.2025.01.007","volume":"43","author":"P Russo","year":"2025","unstructured":"Russo P, Foschi N, Palermo G, Maioriello G, Lentini N, Iacovelli R, et al. SIRI as a biomarker for bladder neoplasm: Utilizing decision curve analysis to evaluate clinical net benefit. Urol Oncol. 2025;43(6):393. e1-393.e8.","journal-title":"Urol Oncol"},{"issue":"13","key":"2086_CR16","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.3390\/cancers17132189","volume":"17","author":"FP Bizzarri","year":"2025","unstructured":"Bizzarri FP, Campetella M, Russo P, Palermo G, Moosavi SK, Rossi F, et al. Prognostic value of PLR, SIRI, PIV, SII, and NLR in Non-Muscle invasive bladder cancer: can inflammatory factors influence pathogenesis and outcomes? Cancers (Basel). 2025;17(13):2189.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2086_CR17","doi-asserted-by":"publisher","first-page":"886","DOI":"10.21037\/tlcr.2019.11.16","volume":"8","author":"H Mandaliya","year":"2019","unstructured":"Mandaliya H, Jones M, Oldmeadow C, Nordman IIC. Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI). Transl Lung Cancer Res. 2019;8(6):886\u201394.","journal-title":"Transl Lung Cancer Res"},{"issue":"21","key":"2086_CR18","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1002\/cncr.28890","volume":"120","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, Pezaro C, Omlin A, McNamara MG, Leibowitz-Amit R, Vera\u2010Badillo FE, et al. Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio. Cancer. 2014;120(21):3346\u201352.","journal-title":"Cancer"},{"key":"2086_CR19","doi-asserted-by":"publisher","first-page":"7971415","DOI":"10.1155\/2022\/7971415","volume":"2022","author":"W Chen","year":"2022","unstructured":"Chen W, Xin S, Xu B. Value research of NLR, PLR, and RDW in prognostic assessment of patients with colorectal cancer. J Healthc Eng. 2022;2022:7971415.","journal-title":"J Healthc Eng"},{"issue":"2","key":"2086_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1538-7836.2010.04131.x","volume":"9","author":"NM Bambace","year":"2011","unstructured":"Bambace NM, Holmes CE. The platelet contribution to cancer progression. J Thromb Haemost. 2011;9(2):237\u201349.","journal-title":"J Thromb Haemost"},{"issue":"19","key":"2086_CR21","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.3390\/cancers13195018","volume":"13","author":"L M\u00fcller","year":"2021","unstructured":"M\u00fcller L, Hahn F, M\u00e4hringer-Kunz A, Stoehr F, Gairing SJ, Michel M, et al. Immunonutritive scoring for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: evaluation of the CALLY index. Cancers (Basel). 2021;13(19):5018.","journal-title":"Cancers (Basel)"},{"key":"2086_CR22","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.2147\/CMAR.S359968","volume":"14","author":"W Wang","year":"2022","unstructured":"Wang W, Gu J, Liu Y, Liu X, Jiang L, Wu C, et al. Pre-Treatment CRP-Albumin-Lymphocyte index (CALLY index) as a prognostic biomarker of survival in patients with epithelial ovarian cancer. Cancer Manag Res. 2022;14:2803\u201312.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"2086_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11060-010-0290-x","volume":"102","author":"G Reyn\u00e9s","year":"2011","unstructured":"Reyn\u00e9s G, Vila V, Mart\u00edn M, Parada A, Fleitas T, Reganon E, et al. Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma. J Neurooncol. 2011;102(1):35\u201341.","journal-title":"J Neurooncol"},{"issue":"5","key":"2086_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/01635581.2016.1159702","volume":"68","author":"GW Yim","year":"2016","unstructured":"Yim GW, Eoh KJ, Kim SW, Nam EJ, Kim YT. Malnutrition identified by the nutritional risk index and poor prognosis in advanced epithelial ovarian carcinoma. Nutr Cancer. 2016;68(5):772\u20139.","journal-title":"Nutr Cancer"},{"issue":"8","key":"2086_CR25","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.3390\/cancers15082212","volume":"15","author":"L Kruk","year":"2023","unstructured":"Kruk L, Mamtimin M, Braun A, Anders H-J, Andrassy J, Gudermann T, et al. Inflammatory networks in renal cell carcinoma. Cancers (Basel). 2023;15(8):2212.","journal-title":"Cancers (Basel)"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02086-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02086-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02086-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:46:49Z","timestamp":1774432009000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02086-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2086"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02086-5","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Clinical Research Ethics Committee of Mersin University (approval number: 2025\/552, dated 19.02.2025) and permission was obtained. Due to the retrospective nature of the study, written informed consent was not obtained from the patients and the procedures were in accordance with those outlined by the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}